Cargando…

A time series analysis of detection and mortality of hepatitis C in Brazil, 2008–2018

BACKGROUND: The 69th World Health Assembly approved the Global Health Sector Strategy to eliminate hepatitis C virus (HCV) infection by 2030. In Brazil, efforts have been undertaken to achieve this goal; there are, however, great challenges. It is important to understand the disease profile in diffe...

Descripción completa

Detalles Bibliográficos
Autores principales: de Brito, Rodrigo José Videres Cordeiro, da Silva, Leonardo Feitosa, Santos, Márcio Bezerra, de Moura, Patrícia Muniz Mendes Freire, de Souza, Carlos Dornels Freire, do Carmo, Rodrigo Feliciano
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8785020/
https://www.ncbi.nlm.nih.gov/pubmed/35073878
http://dx.doi.org/10.1186/s12879-022-07063-5
_version_ 1784638870478913536
author de Brito, Rodrigo José Videres Cordeiro
da Silva, Leonardo Feitosa
Santos, Márcio Bezerra
de Moura, Patrícia Muniz Mendes Freire
de Souza, Carlos Dornels Freire
do Carmo, Rodrigo Feliciano
author_facet de Brito, Rodrigo José Videres Cordeiro
da Silva, Leonardo Feitosa
Santos, Márcio Bezerra
de Moura, Patrícia Muniz Mendes Freire
de Souza, Carlos Dornels Freire
do Carmo, Rodrigo Feliciano
author_sort de Brito, Rodrigo José Videres Cordeiro
collection PubMed
description BACKGROUND: The 69th World Health Assembly approved the Global Health Sector Strategy to eliminate hepatitis C virus (HCV) infection by 2030. In Brazil, efforts have been undertaken to achieve this goal; there are, however, great challenges. It is important to understand the disease profile in different regions of the country in order to design strategies to fight the disease nationwide. The objective of this study was to analyse the time trend of the incidence and mortality of hepatitis C in Brazil during the period from 2008 to 2018 according to sociodemographic and clinical characteristics. METHODS: All newly diagnosed cases of hepatitis C reported between 2008 and 2018, in all regions of Brazil, were included. The indicators were obtained from the databases of the Brazilian Ministry of Health. For the time series analysis, a joinpoint regression model was used. RESULTS: Between 2008 and 2018, 136,759 newly diagnosed cases of hepatitis C were reported considering anti-HCV and HCV RNA positivity, and 271,624 newly diagnosed cases were reported considering one or another positive test. The majority of the records were concentrated in the Southeast (61%) and South (26.2%) Regions. The joinpoint regression model indicated an increasing trend in the detection rate of hepatitis C in Brazil, but there was a decreasing trend in the mortality rate during the period analysed. CONCLUSIONS: Differences were observed in the time trend of hepatitis C and in the sociodemographic and clinical characteristics in different regions of Brazil. These data can provide support to design strategies for the elimination of hepatitis C in Brazil, according to regional particularities.
format Online
Article
Text
id pubmed-8785020
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-87850202022-01-24 A time series analysis of detection and mortality of hepatitis C in Brazil, 2008–2018 de Brito, Rodrigo José Videres Cordeiro da Silva, Leonardo Feitosa Santos, Márcio Bezerra de Moura, Patrícia Muniz Mendes Freire de Souza, Carlos Dornels Freire do Carmo, Rodrigo Feliciano BMC Infect Dis Research BACKGROUND: The 69th World Health Assembly approved the Global Health Sector Strategy to eliminate hepatitis C virus (HCV) infection by 2030. In Brazil, efforts have been undertaken to achieve this goal; there are, however, great challenges. It is important to understand the disease profile in different regions of the country in order to design strategies to fight the disease nationwide. The objective of this study was to analyse the time trend of the incidence and mortality of hepatitis C in Brazil during the period from 2008 to 2018 according to sociodemographic and clinical characteristics. METHODS: All newly diagnosed cases of hepatitis C reported between 2008 and 2018, in all regions of Brazil, were included. The indicators were obtained from the databases of the Brazilian Ministry of Health. For the time series analysis, a joinpoint regression model was used. RESULTS: Between 2008 and 2018, 136,759 newly diagnosed cases of hepatitis C were reported considering anti-HCV and HCV RNA positivity, and 271,624 newly diagnosed cases were reported considering one or another positive test. The majority of the records were concentrated in the Southeast (61%) and South (26.2%) Regions. The joinpoint regression model indicated an increasing trend in the detection rate of hepatitis C in Brazil, but there was a decreasing trend in the mortality rate during the period analysed. CONCLUSIONS: Differences were observed in the time trend of hepatitis C and in the sociodemographic and clinical characteristics in different regions of Brazil. These data can provide support to design strategies for the elimination of hepatitis C in Brazil, according to regional particularities. BioMed Central 2022-01-24 /pmc/articles/PMC8785020/ /pubmed/35073878 http://dx.doi.org/10.1186/s12879-022-07063-5 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
de Brito, Rodrigo José Videres Cordeiro
da Silva, Leonardo Feitosa
Santos, Márcio Bezerra
de Moura, Patrícia Muniz Mendes Freire
de Souza, Carlos Dornels Freire
do Carmo, Rodrigo Feliciano
A time series analysis of detection and mortality of hepatitis C in Brazil, 2008–2018
title A time series analysis of detection and mortality of hepatitis C in Brazil, 2008–2018
title_full A time series analysis of detection and mortality of hepatitis C in Brazil, 2008–2018
title_fullStr A time series analysis of detection and mortality of hepatitis C in Brazil, 2008–2018
title_full_unstemmed A time series analysis of detection and mortality of hepatitis C in Brazil, 2008–2018
title_short A time series analysis of detection and mortality of hepatitis C in Brazil, 2008–2018
title_sort time series analysis of detection and mortality of hepatitis c in brazil, 2008–2018
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8785020/
https://www.ncbi.nlm.nih.gov/pubmed/35073878
http://dx.doi.org/10.1186/s12879-022-07063-5
work_keys_str_mv AT debritorodrigojoseviderescordeiro atimeseriesanalysisofdetectionandmortalityofhepatitiscinbrazil20082018
AT dasilvaleonardofeitosa atimeseriesanalysisofdetectionandmortalityofhepatitiscinbrazil20082018
AT santosmarciobezerra atimeseriesanalysisofdetectionandmortalityofhepatitiscinbrazil20082018
AT demourapatriciamunizmendesfreire atimeseriesanalysisofdetectionandmortalityofhepatitiscinbrazil20082018
AT desouzacarlosdornelsfreire atimeseriesanalysisofdetectionandmortalityofhepatitiscinbrazil20082018
AT docarmorodrigofeliciano atimeseriesanalysisofdetectionandmortalityofhepatitiscinbrazil20082018
AT debritorodrigojoseviderescordeiro timeseriesanalysisofdetectionandmortalityofhepatitiscinbrazil20082018
AT dasilvaleonardofeitosa timeseriesanalysisofdetectionandmortalityofhepatitiscinbrazil20082018
AT santosmarciobezerra timeseriesanalysisofdetectionandmortalityofhepatitiscinbrazil20082018
AT demourapatriciamunizmendesfreire timeseriesanalysisofdetectionandmortalityofhepatitiscinbrazil20082018
AT desouzacarlosdornelsfreire timeseriesanalysisofdetectionandmortalityofhepatitiscinbrazil20082018
AT docarmorodrigofeliciano timeseriesanalysisofdetectionandmortalityofhepatitiscinbrazil20082018